HCSGD entry for TNF


1. General information

Official gene symbolTNF
Entrez ID7124
Gene full nametumor necrosis factor
Other gene symbolsDIF TNF-alpha TNFA TNFSF2
Links to Entrez GeneLinks to Entrez Gene

2. Neighbors in the network

color bar
This gene isn't in PPI subnetwork.

3. Gene ontology annotation

GO ID

GO term

Evidence

Category

GO:0000060Protein import into nucleus, translocationIDAbiological_process
GO:0000122Negative regulation of transcription from RNA polymerase II promoterIDAbiological_process
GO:0000165MAPK cascadeIMPbiological_process
GO:0000185Activation of MAPKKK activityIDAbiological_process
GO:0000187Activation of MAPK activityIDAbiological_process
GO:0001666Response to hypoxiaIEAbiological_process
GO:0001775Cell activationIEAbiological_process
GO:0001819Positive regulation of cytokine productionIDAbiological_process
GO:0001891Phagocytic cupISScellular_component
GO:0001934Positive regulation of protein phosphorylationIDAbiological_process
GO:0002020Protease bindingIPImolecular_function
GO:0002037Negative regulation of L-glutamate transportIEAbiological_process
GO:0002439Chronic inflammatory response to antigenic stimulusIMPbiological_process
GO:0002740Negative regulation of cytokine secretion involved in immune responseIDAbiological_process
GO:0002876Positive regulation of chronic inflammatory response to antigenic stimulusIEAbiological_process
GO:0002925Positive regulation of humoral immune response mediated by circulating immunoglobulinIEAbiological_process
GO:0003009Skeletal muscle contractionIEAbiological_process
GO:0005125Cytokine activityIDAmolecular_function
GO:0005164Tumor necrosis factor receptor bindingIDAmolecular_function
GO:0005515Protein bindingIPImolecular_function
GO:0005576Extracellular regionTAScellular_component
GO:0005615Extracellular spaceIDAcellular_component
GO:0005886Plasma membraneTAScellular_component
GO:0005887Integral component of plasma membraneIDAcellular_component
GO:0006006Glucose metabolic processIEAbiological_process
GO:0006915Apoptotic processTASbiological_process
GO:0006919Activation of cysteine-type endopeptidase activity involved in apoptotic processIDAbiological_process
GO:0006927Transformed cell apoptotic processIDAbiological_process
GO:0006954Inflammatory responseIDAbiological_process
GO:0006959Humoral immune responseIEAbiological_process
GO:0007254JNK cascadeIEAbiological_process
GO:0008285Negative regulation of cell proliferationIEAbiological_process
GO:0008625Extrinsic apoptotic signaling pathway via death domain receptorsIDA NASbiological_process
GO:0008630Intrinsic apoptotic signaling pathway in response to DNA damageIEAbiological_process
GO:0008652Cellular amino acid biosynthetic processIEAbiological_process
GO:0009612Response to mechanical stimulusIEAbiological_process
GO:0009615Response to virusIDAbiological_process
GO:0009651Response to salt stressTASbiological_process
GO:0009887Organ morphogenesisIEAbiological_process
GO:0009897External side of plasma membraneISScellular_component
GO:0009986Cell surfaceIDAcellular_component
GO:0010629Negative regulation of gene expressionIDAbiological_process
GO:0010693Negative regulation of alkaline phosphatase activityIEAbiological_process
GO:0010888Negative regulation of lipid storageNASbiological_process
GO:0010940Positive regulation of necrotic cell deathTASbiological_process
GO:0014823Response to activityIEAbiological_process
GO:0019722Calcium-mediated signalingIEAbiological_process
GO:0030198Extracellular matrix organizationIEAbiological_process
GO:0030316Osteoclast differentiationIEAbiological_process
GO:0030730Sequestering of triglycerideIDAbiological_process
GO:0031334Positive regulation of protein complex assemblyIDAbiological_process
GO:0031622Positive regulation of fever generationISSbiological_process
GO:0031663Lipopolysaccharide-mediated signaling pathwayIDAbiological_process
GO:0032715Negative regulation of interleukin-6 productionIDAbiological_process
GO:0032722Positive regulation of chemokine productionIDAbiological_process
GO:0032729Positive regulation of interferon-gamma productionIEAbiological_process
GO:0032741Positive regulation of interleukin-18 productionIEAbiological_process
GO:0032755Positive regulation of interleukin-6 productionIEAbiological_process
GO:0032800Receptor biosynthetic processIDAbiological_process
GO:0033138Positive regulation of peptidyl-serine phosphorylationIDAbiological_process
GO:0033209Tumor necrosis factor-mediated signaling pathwayIMPbiological_process
GO:0034116Positive regulation of heterotypic cell-cell adhesionIDAbiological_process
GO:0042346Positive regulation of NF-kappaB import into nucleusIDAbiological_process
GO:0042493Response to drugIEAbiological_process
GO:0042802Identical protein bindingIDAmolecular_function
GO:0043065Positive regulation of apoptotic processIDAbiological_process
GO:0043068Positive regulation of programmed cell deathIDAbiological_process
GO:0043122Regulation of I-kappaB kinase/NF-kappaB signalingIDAbiological_process
GO:0043123Positive regulation of I-kappaB kinase/NF-kappaB signalingIDAbiological_process
GO:0043242Negative regulation of protein complex disassemblyIDAbiological_process
GO:0043243Positive regulation of protein complex disassemblyIDAbiological_process
GO:0043280Positive regulation of cysteine-type endopeptidase activity involved in apoptotic processIDAbiological_process
GO:0043406Positive regulation of MAP kinase activityIDAbiological_process
GO:0043491Protein kinase B signalingIMPbiological_process
GO:0043507Positive regulation of JUN kinase activityIDAbiological_process
GO:0043525Positive regulation of neuron apoptotic processIEAbiological_process
GO:0044130Negative regulation of growth of symbiont in hostIEAbiological_process
GO:0044212Transcription regulatory region DNA bindingIDAmolecular_function
GO:0045071Negative regulation of viral genome replicationIDAbiological_process
GO:0045080Positive regulation of chemokine biosynthetic processIDAbiological_process
GO:0045121Membrane raftIDAcellular_component
GO:0045416Positive regulation of interleukin-8 biosynthetic processIDAbiological_process
GO:0045429Positive regulation of nitric oxide biosynthetic processIDAbiological_process
GO:0045599Negative regulation of fat cell differentiationNASbiological_process
GO:0045668Negative regulation of osteoblast differentiationIEAbiological_process
GO:0045672Positive regulation of osteoclast differentiationIDAbiological_process
GO:0045840Positive regulation of mitosisIEAbiological_process
GO:0045892Negative regulation of transcription, DNA-templatedIDAbiological_process
GO:0045893Positive regulation of transcription, DNA-templatedIDAbiological_process
GO:0045944Positive regulation of transcription from RNA polymerase II promoterIDA IGIbiological_process
GO:0045994Positive regulation of translational initiation by ironIEAbiological_process
GO:0046325Negative regulation of glucose importIEAbiological_process
GO:0046330Positive regulation of JNK cascadeIEAbiological_process
GO:0048566Embryonic digestive tract developmentIEPbiological_process
GO:0048661Positive regulation of smooth muscle cell proliferationIDAbiological_process
GO:0050715Positive regulation of cytokine secretionIDAbiological_process
GO:0050796Regulation of insulin secretionIDAbiological_process
GO:0050806Positive regulation of synaptic transmissionIEAbiological_process
GO:0050830Defense response to Gram-positive bacteriumIEAbiological_process
GO:0050901Leukocyte tethering or rollingIDAbiological_process
GO:0050995Negative regulation of lipid catabolic processIDAbiological_process
GO:0051023Regulation of immunoglobulin secretionIEAbiological_process
GO:0051044Positive regulation of membrane protein ectodomain proteolysisIDAbiological_process
GO:0051091Positive regulation of sequence-specific DNA binding transcription factor activityIDAbiological_process
GO:0051092Positive regulation of NF-kappaB transcription factor activityIDAbiological_process
GO:0051222Positive regulation of protein transportIDAbiological_process
GO:0051384Response to glucocorticoidIDAbiological_process
GO:0051533Positive regulation of NFAT protein import into nucleusIDAbiological_process
GO:0051798Positive regulation of hair follicle developmentIEAbiological_process
GO:0051897Positive regulation of protein kinase B signalingIEAbiological_process
GO:0055037Recycling endosomeISScellular_component
GO:0060557Positive regulation of vitamin D biosynthetic processIDAbiological_process
GO:0060559Positive regulation of calcidiol 1-monooxygenase activityIDAbiological_process
GO:0060664Epithelial cell proliferation involved in salivary gland morphogenesisIEAbiological_process
GO:0060693Regulation of branching involved in salivary gland morphogenesisIEAbiological_process
GO:0061048Negative regulation of branching involved in lung morphogenesisIDAbiological_process
GO:0070265Necrotic cell deathIDAbiological_process
GO:0070374Positive regulation of ERK1 and ERK2 cascadeNASbiological_process
GO:0071230Cellular response to amino acid stimulusIEAbiological_process
GO:0071316Cellular response to nicotineIDAbiological_process
GO:0071407Cellular response to organic cyclic compoundIDAbiological_process
GO:0071677Positive regulation of mononuclear cell migrationNASbiological_process
GO:0071803Positive regulation of podosome assemblyIDAbiological_process
GO:0097190Apoptotic signaling pathwayTASbiological_process
GO:0097191Extrinsic apoptotic signaling pathwayIDAbiological_process
GO:0097527Necroptotic signaling pathwayIDAbiological_process
GO:1902043Positive regulation of extrinsic apoptotic signaling pathway via death domain receptorsIEAbiological_process
GO:2000010Positive regulation of protein localization to cell surfaceIDAbiological_process
GO:2000343Positive regulation of chemokine (C-X-C motif) ligand 2 productionIDAbiological_process
GO:2001240Negative regulation of extrinsic apoptotic signaling pathway in absence of ligandIDAbiological_process
Entries Per Page
Displaying Page of

4. Expression levels in datasets

  • Meta-analysis result

p-value upp-value downFDR upFDR down
0.54404341020.88122844880.99999024731.0000000000

  • Individual experiment result
    ( "-" represent NA in the specific microarray platform )

Data sourceUp or downLog fold change
GSE11954Up0.0194788988
GSE13712_SHEARUp0.1344824462
GSE13712_STATICDown-0.0903697046
GSE19018Up0.1231898768
GSE19899_A1Down-0.0058511665
GSE19899_A2Down-0.3686982128
PubMed_21979375_A1Down-0.0906462953
PubMed_21979375_A2Down-0.0858993620
GSE35957Up0.0860493550
GSE36640Up0.0994947636
GSE54402Up0.0457163384
GSE9593Up0.1265056758
GSE43922Up0.0674889738
GSE24585Up0.2546662673
GSE37065Up0.0250861875
GSE28863_A1Down-0.0004431785
GSE28863_A2Up0.1431519688
GSE28863_A3Up0.0541690061
GSE28863_A4Up0.1280788192
GSE48662Up0.0224178188

5. Regulation relationships with compounds/drugs/microRNAs

  • Compounds

Compound

Target

Confidence score

Uniprot

CHEMBL183474CHEMBL18259P01375
CHEMBL363126CHEMBL18259P01375
CHEMBL186663CHEMBL18259P01375
CHEMBL360854CHEMBL18259P01375
CHEMBL436277CHEMBL18259P01375
CHEMBL187245CHEMBL18259P01375
CHEMBL187852CHEMBL18259P01375
CHEMBL183995CHEMBL18259P01375
CHEMBL187141CHEMBL18259P01375
CHEMBL148351CHEMBL18259P01375
CHEMBL426975CHEMBL18259P01375
CHEMBL186500CHEMBL18259P01375
CHEMBL446697CHEMBL18259P01375
CHEMBL182306CHEMBL18259P01375
CHEMBL365283CHEMBL18259P01375
CHEMBL148169CHEMBL18259P01375
CHEMBL436071CHEMBL18259P01375
CHEMBL365247CHEMBL18259P01375
CHEMBL187474CHEMBL18259P01375
CHEMBL436071CHEMBL18259P01375
CHEMBL369115CHEMBL18259P01375
CHEMBL342076CHEMBL18259P01375
CHEMBL186743CHEMBL18259P01375
CHEMBL1630106CHEMBL18259P01375
CHEMBL402030CHEMBL18259P01375
CHEMBL1630098CHEMBL18259P01375
CHEMBL1630101CHEMBL18259P01375
CHEMBL148169CHEMBL18259P01375
CHEMBL1630088CHEMBL18259P01375
CHEMBL1630104CHEMBL18259P01375
CHEMBL1630100CHEMBL18259P01375
CHEMBL1630105CHEMBL18259P01375
CHEMBL1630102CHEMBL18259P01375
CHEMBL1630103CHEMBL18259P01375
CHEMBL1630089CHEMBL18259P01375
CHEMBL1630091CHEMBL18259P01375
CHEMBL1630090CHEMBL18259P01375
CHEMBL143134CHEMBL18258P01375
CHEMBL143373CHEMBL18258P01375
CHEMBL104991CHEMBL18258P01375
CHEMBL336001CHEMBL18258P01375
CHEMBL11440CHEMBL18258P01375
CHEMBL344625CHEMBL18258P01375
CHEMBL143134CHEMBL18258P01375
CHEMBL318810CHEMBL18258P01375
CHEMBL104991CHEMBL18258P01375
CHEMBL143886CHEMBL18258P01375
CHEMBL103667CHEMBL18258P01375
CHEMBL344625CHEMBL18258P01375
CHEMBL344800CHEMBL18258P01375
CHEMBL143373CHEMBL18258P01375
CHEMBL344800CHEMBL18258P01375
CHEMBL142115CHEMBL18258P01375
CHEMBL103667CHEMBL18258P01375
CHEMBL318810CHEMBL18258P01375
CHEMBL142115CHEMBL18258P01375
CHEMBL143886CHEMBL18258P01375
CHEMBL336001CHEMBL18258P01375
CHEMBL171406CHEMBL18258P01375
CHEMBL111544CHEMBL18258P01375
CHEMBL126353CHEMBL18258P01375
CHEMBL127990CHEMBL18258P01375
CHEMBL171179CHEMBL18258P01375
CHEMBL419775CHEMBL18258P01375
CHEMBL352725CHEMBL18258P01375
CHEMBL320347CHEMBL18258P01375
CHEMBL322553CHEMBL18258P01375
CHEMBL18701CHEMBL18258P01375
CHEMBL126816CHEMBL18258P01375
CHEMBL419204CHEMBL18258P01375
CHEMBL125787CHEMBL18258P01375
CHEMBL171989CHEMBL18258P01375
CHEMBL126434CHEMBL18258P01375
CHEMBL126415CHEMBL18258P01375
CHEMBL110110CHEMBL18258P01375
CHEMBL110421CHEMBL18258P01375
CHEMBL169795CHEMBL18258P01375
CHEMBL545531CHEMBL18258P01375
CHEMBL170855CHEMBL18258P01375
CHEMBL108710CHEMBL18258P01375
CHEMBL126945CHEMBL18258P01375
CHEMBL113442CHEMBL18258P01375
CHEMBL109264CHEMBL18258P01375
CHEMBL89890CHEMBL18258P01375
CHEMBL111111CHEMBL18258P01375
CHEMBL109316CHEMBL18258P01375
CHEMBL333333CHEMBL18258P01375
CHEMBL263480CHEMBL18258P01375
CHEMBL341096CHEMBL18258P01375
CHEMBL63CHEMBL18258P01375
CHEMBL327083CHEMBL18258P01375
CHEMBL174253CHEMBL18258P01375
CHEMBL355042CHEMBL18258P01375
CHEMBL544359CHEMBL18258P01375
CHEMBL172669CHEMBL18258P01375
CHEMBL114343CHEMBL18258P01375
CHEMBL127466CHEMBL18258P01375
CHEMBL127390CHEMBL18258P01375
CHEMBL174254CHEMBL18258P01375
CHEMBL126246CHEMBL18258P01375
CHEMBL340346CHEMBL18258P01375
CHEMBL628CHEMBL18258P01375
CHEMBL124975CHEMBL18258P01375
CHEMBL125674CHEMBL18258P01375
CHEMBL323009CHEMBL18258P01375
CHEMBL127149CHEMBL18258P01375
CHEMBL127042CHEMBL18258P01375
CHEMBL111503CHEMBL18258P01375
CHEMBL170479CHEMBL18258P01375
CHEMBL555277CHEMBL18258P01375
CHEMBL414243CHEMBL18258P01375
CHEMBL110949CHEMBL18258P01375
CHEMBL126867CHEMBL18258P01375
CHEMBL170920CHEMBL18258P01375
CHEMBL127198CHEMBL18258P01375
CHEMBL127478CHEMBL18258P01375
CHEMBL169239CHEMBL18258P01375
CHEMBL111560CHEMBL18258P01375
CHEMBL126817CHEMBL18258P01375
CHEMBL111973CHEMBL18258P01375
CHEMBL255489CHEMBL18258P01375
CHEMBL414429CHEMBL18258P01375
CHEMBL418836CHEMBL18258P01375
CHEMBL125632CHEMBL18258P01375
CHEMBL127042CHEMBL18258P01375
CHEMBL340097CHEMBL18258P01375
CHEMBL126283CHEMBL18258P01375
CHEMBL368458CHEMBL18258P01375
CHEMBL127148CHEMBL18258P01375
CHEMBL127259CHEMBL18258P01375
CHEMBL127144CHEMBL18258P01375
CHEMBL423609CHEMBL18258P01375
CHEMBL321032CHEMBL18258P01375
CHEMBL338765CHEMBL18258P01375
CHEMBL127003CHEMBL18258P01375
CHEMBL322814CHEMBL18258P01375
CHEMBL126249CHEMBL18258P01375
CHEMBL88935CHEMBL18258P01375
CHEMBL354257CHEMBL18258P01375
CHEMBL110956CHEMBL18258P01375
Entries Per Page
Displaying Page of

  • Drugs

Name

Drug

Accession number

EtanerceptDB00005 BTD00052 | BIOD00052
AdalimumabDB00051 BTD00049 | BIOD00049
InfliximabDB00065 BTD00004 | BIOD00004
ChloroquineDB00608 APRD00468
GlucosamineDB01296 EXPT01563
PranlukastDB01411 -
AmrinoneDB01427 -
Isopropyl AlcoholDB02325 EXPT01912 | DB04402
AfelimomabDB04956 -
YSIL6DB05017 -
AV411DB05066 -
SD118DB05207 -
PN0621DB05218 -
681323DB05250 -
OMS-103HPDB05303 -
SCIO-469DB05412 -
VX-702DB05470 -
ApremilastDB05676 -
CRx-139DB05744 -
CYT007-TNFQbDB05758 -
HMPL-004DB05767 -
CTI-01DB05869 -
AME-527DB05879 -
GolimumabDB06674 -
Certolizumab pegolDB08904 -
PomalidomideDB08910 -

  • MicroRNAs

    • mirTarBase

MiRNA_name

mirBase ID

miRTarBase ID

Experiment

Support type

References (Pubmed ID)

hsa-miR-203aMIMAT0000264MIRT006857Luciferase reporter assayFunctional MTI22917968
Entries Per Page
Displaying Page of
    • mirRecord

MicroRNA name

mirBase ID

Target site number

MiRNA mature ID

Test method inter

MiRNA regulation site

Reporter target site

Pubmed ID

hsa-miR-19a-3pMIMAT00000731hsa-miR-19a{Western blot}{downregulation by anti-miRNA oligonucleotide}21271217
Entries Per Page
Displaying Page of

6. Text-mining results about the gene

Gene occurances in abstracts of cellular senescence-associated articles: 81 abstracts the gene occurs.


PubMed ID of the article

Sentenece the gene occurs

27917303Then, the effect of synthetic miR-146a mimetic on IL-6 and VEGF-A expression was analyzed in RPE cells treated with and without TNF-alpha
27547293Compared to their normobilirubinemic siblings, aged hyperbilirubinemic Gunn rats showed significantly smaller amounts of visceral fat, better glucose tolerance, and decreased serum levels of proinflammatory cytokines TNFalpha, IL-1beta, and IL-18
27147278Prominent examples include aberrations in cytokines and their signaling pathways (such as tumor necrosis factor-alpha, interferon-gamma, SMAD proteins), mutations in genes encoding the RNA splicing machinery (SF3B1, SRSF2, ZRSR2, and U2AF1 genes), mutations in genes disrupting the epigenetic machinery (TET2, DNMT3A, DNMT3B, EZH2, ASXL1)
27076598Endogenous Transmembrane TNF-Alpha Protects Against Premature Senescence in Endothelial Colony Forming Cells
27076598RATIONALE: Transmembrane tumor necrosis factor-alpha (tmTNF-alpha) is the prime ligand for TNF receptor 2, which has been shown to mediate angiogenic and blood vessel repair activities in mice
27076598Indeed, the mechanism of chronic inflammation-induced premature senescence involves an abrogation of tmTNF/TNF receptor 2 signaling
26943583Aim of this study was to evaluate whether and how adalimumab, a monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), a major SASP component, can prevent the SASP
26943583TNF-alpha blockade associated with adalimumab induced significant reduction in released IL-6 and significant increase in eNOS and miR-126-3p expression levels in long-term HUVEC cultures
26924930In present study, agmatine attenuated the cell death and the expression of pro-inflammatory cytokines such as IL-6, TNF-alpha and CCL2 in high glucose in vitro conditions
26522327By contrast, inflammatory stimuli such as lipopolysaccharide (LPS) and tumor necrosis factor-alpha promoted HMGB1 release by provoking its dissociation from SIRT1 dependent on acetylation, thereby increasing the association between HMGB1 and chromosome region maintenance 1, leading to HMGB1 translocation
26521742Systemic inflammation can be promoted by aging changes in adipose tissue that result in increased production of cytokines such as interleukin (IL)-6 and tumor necrosis factor-alpha (TNFalpha)
26388614Disc in flames: Roles of TNF-alpha and IL-1beta in intervertebral disc degeneration
26388614Inflammatory processes exacerbated by cytokines tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) are believed to be key mediators of disc degeneration and low back pain
26388614In this review, we describe the contributions of TNF-alpha and IL-1beta to changes seen during disc degeneration at both cellular and tissue level, as well as new evidence suggesting a link between infection of the spine and low back pain, and the emerging therapeutic modalities aimed at combating these processes
26240351Concomitantly, increased cellular senescence in the adipose tissue from pol eta(-/-) mice was observed and measured by up-regulation of senescence markers, including p53, p16(Ink4a), p21, senescence-associated (SA) beta-gal activity, and SA secretion of proinflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) as early as 4 wk of age
26142204Vasodilator responses to acetylcholine (Ach) in the isolated aortic rings were measured, serum concentration of glucose, tumor necrosis factor-alpha (TNF-alpha) and monocyte chemoattractant protein-1 (MCP-1) and the expression of VPO1 in the aorta were determined
26142204Endothelial cells were treated with high glucose or H2O2, the concentrations of MCP-1, TNF-alpha and hypochlorous acid (HOCl) and the expression of VPO1 were determined
26142204RESULTS: Vasodilator responses to Ach were impaired markedly and the serum concentrations of glucose, TNF-alpha and MCP-1 were significantly increased in diabetic rats
26142204High glucose treatment significantly decreased cell viability and elevated the levels of MCP-1, TNF-alpha and HOCl and upregulated the expression of VPO1
26105007Upon LPS treatment, SV cells also developed senescence-associated secretory phenotype (SASP), as demonstrated by the increased expression of TNFalpha, IL-1beta, IL-6, MCP-1, and VEGFalpha
26091153In vitro data suggested a mechanism implicating a role of TNF-alpha and IL-1beta in disc autophagy
25989853Functionally, impaired actin dynamics resulted in reduced NO secretion and reduced release of TNFalpha and IL-6 from LPS-stimulated microglia and of IGF-1 from IL-4 stimulated microglia
25982278While cytokines such as tumor necrosis factor-alpha (TNFalpha) and interferon gamma (IFNgamma) are important components of senescence-associated secretome and induce senescence in, for example, mouse pancreatic beta-cancer cell model, their downstream signaling pathway(s) and links with oxidative stress and DDR are mechanistically unclear
25982278Using human and mouse normal and cancer cell models, we now show that TNFalpha and IFNgamma induce NADPH oxidases Nox4 and Nox1, reactive oxygen species (ROS), DDR signaling and premature senescence
25982278Unlike mouse tumor cells that required concomitant presence of IFNgamma and TNFalpha, short exposure to IFNgamma alone was sufficient to induce Nox4, Nox1 and DDR in human cells
25894557The penises injected with the senescent cells expressed human IL-1beta and subsequently endogenous proinflammatory cytokines such as mouse IL-1beta and tumor necrosis factor-alpha
25572145Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-kappaB activation induced by TNF-alpha concurrently increasing senescence and survival
25572145Re-expression of E2 expression with TNF-alpha treatment resulted in an increase in the expression of anti-apoptotic Bcl2 (B-cell lymphoma 2) protein and other pro-survival genes like cyclin D1 (cyc D1), survivin and hTERT (human telomerase reverse transcriptase)
25572145Concomitantly, E2 + TNF-alpha combination increased the survival of SiHa cells by positive changes in viability, proliferation and colony formation
25572145E2-induced apoptotic tendency shifted towards senescence in presence of TNF-alpha by arresting the cells at both G0/G1 and G2/M phases, thus enhancing cell survival
25572145Another observation in the present study is the significant up-regulation of key senescence messaging factors regulated by NF-kappaB namely interleukin (IL)-6, IL-8, high-mobility group protein A (HMGA)1 and B (HMGB)1 in E2-transfected cells treated with TNF-alpha
25572145Our data provide a mechanistic basis and a new insight for the role of TNF-alpha and E2 in linking cellular senescence, tumorigenesis and HPV re-infection
25407919ARHGAP18 overexpression induced a predominantly anti-inflammatory senescent population and depletion of the caveolae-associated proteins resulted in the preferential reduction in this senescent population as measured by neutrophil adhesion and adhesion protein expression after TNFalpha treatment
25342130Stimulation of endothelial cells (ECs) with TNF-alpha causes an increase in the expression of bone morphogenetic protein-2 (BMP-2) and the production of endothelial microparticles (EMPs)
25341065OBJECTIVES: Given their common effects, this study investigated whether A1AT acts via PP2A to alter tumor necrosis factor (TNF) signaling, inflammation, and proteolytic responses in this disease
25341065PP2A was silenced in lung epithelial cells treated with A1AT and matrix metalloproteinase and cytokine production was then measured following TNF-alpha stimulation
25341065CONCLUSIONS: Together, these data indicate that A1AT modulates PP2A to counter inflammatory and proteolytic responses induced by TNF signaling in the lung
25319743Stromovascular cell composition (flow cytometry), the number of senescent cells (senescence-associated-beta-galactosidase staining) and interleukin (IL)-6, IL-1, TNF-alpha and MCP1 mRNA (reverse transcription-PCR) were measured in each sample
25090227Among the anti-inflammatory cytokines, the production of prostaglandin E2 (PGE2) and the expression of its primary enzyme, cyclooxygenase-2 (COX-2), were profoundly increased by pre-stimulation with interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha), and this response was significantly decreased with consecutive passages
25083993Despite their apparent senescent state, we determined that these cells secreted high levels of both TNF-alpha and IFN-gamma and showed potent cytotoxic activity
24979747Further investigation showed that ginsenoside Rg1 protected NSCs/NPCs (neural stem cells/progenitor cells) shown by increased level of SOX-2 expression; reduced astrocytes activation shown by decrease level of Aeg-1 expression; increased the hippocampal cell proliferation; enhanced the activity of the antioxidant enzymes GSH-Px (glutathione peroxidase) and SOD (Superoxide Dismutase); decreased the levels of IL-1beta, IL-6 and TNF-alpha, which are the proinflammatory cytokines; increased the telomere lengths and telomerase activity; and down-regulated the mRNA expression of cellular senescence associated genes p53, p21Cip1/Waf1 and p19Arf in the hippocampus of aged rats
24666525Pretreatment with 17beta-estradiol or genistein inhibited BAEC senescence induced by male or female db/db LDL and downregulated the expression of lectin-like oxidized LDL receptor-1 and tumor necrosis factor-alpha protein
24481487The levels of circulatory inflammatory markers, including interleukin (IL) IL-1beta, IL-6, tumor necrosis factor-alpha (TNF-alpha) and interferon (INF-gamma), are known to increase associated to aging
24481487The two-way ANOVA of TNF-alpha levels revealed a significant exercise x caffeine interaction (F (1, 16) = 9
24439483Inflammation markers (interleukin-6, c-reactive protein, tumor necrosis factor-alpha), hypothalamic-pituitary-adrenal-axis indicators (salivary cortisol awakening curve [area under the curve indicators, with respect to the ground and increase], evening levels, 0
24286133A complex interaction between Wnt signaling and TNF-alpha in nucleus pulposus cells
24286133INTRODUCTION: Increased expression of the proinflammatory cytokine TNF-alpha in intervertebral discs (IVDs) leads to inflammation, which results in progressive IVD degeneration
24286133However, it is not known whether cross talk between TNF-alpha and Wnt signaling plays a role in the regulation of nucleus pulposus cells
24286133The goal of the present study was to examine the effect of the interaction between Wnt signaling and the proinflammatory cytokine TNF-alpha in nucleus pulposus cells
24286133METHODS: Cells isolated from rat nucleus pulposus regions of IVDs were cultured in monolayers, and the expression and promoter activity of Wnt signaling and TNF-alpha were evaluated
24286133We also examined whether the inhibition of Wnt signaling using cotransfection with Dickkopf (DKK) isoforms and Sclerostin (SOST) could block the effects of pathological TNF-alpha expression in nucleus pulposus cells
24286133RESULTS: TNF-alpha stimulated the expression and promoter activity of Wnt signaling in nucleus pulposus cells
24286133In addition, the activation of Wnt signaling by 6-bromoindirubin-3'-oxime (BIO), which is a selective inhibitor of glycogen synthase kinase 3 (GSK-3) activity that activates Wnt signaling, increased TNF-alpha expression and promoter activity
24286133Conversely, the suppression of TNF-alpha promoter activity using a beta-catenin small interfering RNA was evident
24286133Moreover, transfection with DKK-3, DKK-4, or SOST, which are inhibitors of Wnt signaling, blocked Wnt signaling-mediated TNF-alpha activation; these effects were not observed for DKK-1 or DKK-2
24286133CONCLUSIONS: Here, we have demonstrated that Wnt signaling regulates TNF-alpha and that Wnt signaling and TNF-alpha form a positive-feedback loop in nucleus pulposus cells
24286133The results of the present study provide in vitro evidence that activation of Wnt signaling upregulates the TNF-alpha expression and might cause the degeneration of nucleus pulposus cells
24269635In cultured chondrocytes, IL-1beta and TNF-alpha suppressed FOXO1, while TGF-beta and PDGF increased FOXO1 and FOXO3 expression
24063161At 24 hours, 72 hours, and 6 days after culture, the cell morphology and density were observed by inverted microscope; the cell proliferation was assessed by MTT; after 6 days of culture, the cell cycle by propidium iodide staining and flow cytometry, the apoptosis by acridine orange/ ethidium bromide staining, and the cell senescence by beta-galactosidase staining; the levels of tumor necrosis factor alpha (TNF-alpha), interleukin 1 (IL-1), platelet-derived growth factor (PDGF), and insulin-like growth factor 1 (IGF-1) in serum were detected by a double-antibody sandwich ELISA kit
24063161The levels of TNF-alpha, IL-1, PDGF, and IGF-1 in group C were significantly higher than those in group B (P < 0
23952478Morin significantly decreased the production of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in the UVB-irradiated KSC
23940580A higher influx of F4/80(+) macrophages and CD4(+) T lymphocytes is measured and is accompanied by increases in mRNA of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha)
23853351The increased susceptibility of immune inflammatory response, morbidity and mortality in the elderly is often associated with decreased frequencies of anti-inflammatory factor IL-10 -1082G allele, TNF-beta1 haplotype cnd10T/C, cnd25G/G, -988C/C, -800G/A, low proinflammatory fator TNFa level related extended TNF-A genotype -1031C/C, -863C/A, -857C/C, IL-6-174 CC and IFN-gamma+874 T allele as well
23611899For the next 9 days, the cells were cultured in chondrogenic medium containing 50% conditioned medium derived from C2C12 muscle cells or fibroblast control cells, and were subject to treatments of pro-inflammatory cytokines IL-1beta or TNFalpha
26201620Examples include the HLA class-II region and genes implicated in IL12-JAK/STAT signaling, and the NF-kappaB and TNF signaling pathways
23438440A role for TNFalpha in intervertebral disc degeneration: a non-recoverable catabolic shift
23438440Whole bovine discs were cultured to examine cellular (anabolic/catabolic gene expression, cell viability and senescence using beta-galactosidase) and structural (histology and aggrecan degradation) changes in response to TNFalpha treatment
23438440Control or TNFalpha cultures were assessed at 7 and 21 days; the 21 day group also included a recovery group with 7 days TNFalpha followed by 14 days in basal media
23438440TNFalpha induced catabolic and anti-anabolic shifts in the nucleus pulposus (NP) and annulus fibrosus (AF) at 7 days and this persisted until 21 days however cell viability was not affected
23438440Data indicates that TNFalpha increased aggrecan degradation products and suggests increased beta-galactosidase staining at 21 days without any recovery
23438440TNFalpha significantly reduced anabolism in cultured IVDs and a possible mechanism may be associated with cell senescence
23385819Adipocytes subjected to oxidative stress also showed shortened telomeres and increased mRNA and protein expression of p53, p21, TNF alpha and IL-6
23385065Cellular senescence, a permanent state of cell cycle arrest that provides a barrier against tumorigenesis, is accompanied by elevated proinflammatory cytokines such as IL1, IL6, IL8 and TNFalpha
23281008This leads to enhanced secretion of inflammatory cytokines known to drive osteoclastogenesis, such as interleukin-6 (IL-6), tumor necrosis factor alpha (TNFalpha), and receptor activator of NF-kappaB ligand (RANKL), and thereby induces an inflammatory bone microenvironment favoring osteoclastogenesis
23272236To confirm selectivity of the SASP-RAP response, cells were treated with senescence-related and -unrelated stimuli (IL-1beta, LPS, TNF-alpha and TGF-beta), and induction of senescence markers and activity of SASP-RAP were evaluated in parallel
23013131The p21-induced senescent cells express higher levels of apoptotic cytokines, such as tumour necrosis factor (TNF)-alpha compared with non-senescent cells
23013131Exposure of cells to aldosterone for 3 or 5 days increased senescence-associated beta-galactosidase staining, p21 and TNF-alpha mRNA expression and secretion of TNF-alpha into the culture medium
23013131A neutralizing antibody against TNF-alpha prevented the aldosterone-induced apoptotic changes
23013131These findings indicate that aldosterone increases TNF-alpha synthesis and secretion in proximal tubular cells via p21/senescence-dependent cell phenotypic changes and that the TNF-alpha secreted plays an important role as a paracrine factor in mediating cell apoptosis, indicating a possible involvement in aldosterone-induced renal damage
23000105Senescence was also obtained by exposure to TNFalpha, which causes cell changes resembling cellular senescence
23000105Klotho was also reduced in cells exposed to the proinflammatory cytokine TNFalpha
23000105The addition of exogenous Klotho to aging cells did not modify the proportion of cells with short telomeres or any other feature of cell aging; however, exogenous Klotho prevented the changes resembling premature cellular senescence associated with TNFalpha, such as the decrease in telomere length and the increase in beta-galactosidase-positive cells
23000105Likewise exogenous Klotho prevented the increases in reactive oxygen species (ROS) activity, mitochondrial potential and cell apoptosis induced by TNFalpha
226928482 % prevented tBHP-induced reactive oxygen species production (evaluated using the H2DCF-DA test in cytofluorometry) in epithelial cells and LPS-induced TNF-alpha and IL-6 release (evaluated using ELISA technique) in macrophages
22663935We confirmed the importance of inflammatory markers (IL-6, TNF-alpha, CRP, neutrophils) in frailty in the very old, previously established only in younger-old populations
22252437We have recently published that the proinflammatory cytokine TNFalpha is a strong inducer of CD4(+) T-cell senescence and T-cell differentiation, adding to the growing body of literature implicating proinflammatory molecules in mediating these critical age-related T-cell alterations
21985896Based on increases in SMalphaA, stimulation with the proinflammatory cytokine tumor necrosis factor-alpha, but not with TGF-beta, induced EnMT in early passage cells similar to that observed in late passage cells
21738489Here we map Sirt6 occupancy on mouse promoters genome-wide and show that Sirt6 occupancy is highly dynamic in response to TNF-alpha
21698300Compared to early cultures, late passage HUVECs also exhibited nuclear translocation of NF-kappaB (p65) and reciprocal shifts in BAX and BCL2 protein content resulting in almost 2-fold increase in BAX/BCL2 ratio and 3-fold increase in apoptotic response to TNFalpha exposure (p<0
21602933METHODOLOGY/PRINCIPAL FINDINGS: To address this issue, we examined if individuals with high levels of the systemic inflammatory markers interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and C-reactive protein (CRP) had increased odds for short LTL
21602933Logistic regression analyses indicated that individuals with high levels of either IL-6 or TNF-alpha had significantly higher odds for short LTL
21602933Furthermore, individuals with high levels of both IL-6 and TNF-alpha had significantly higher odds for short LTL compared with those who had neither high (OR = 0
2160293383) or only TNF-alpha high (OR = 0
21602933CONCLUSIONS/SIGNIFICANCE: Results suggest that cumulative inflammatory load, as indexed by the combination of high levels of IL-6 and TNF-alpha, is associated with increased odds for short LTL
21562872RESULTS: In Ovx mice, Med/E2 at their respective osteoprotective doses resulted in thymus involution and lowered Ovx-induced increase in serum TNF-alpha level and its mRNA levels in the BM T cells
21212468Zfra (zinc finger-like protein that regulates apoptosis) is a naturally occurring short peptide consisting of 31 amino acids, which regulates tumor necrosis factor (TNF)-mediated cell death by interacting with receptor adaptor protein TRADD (TNF receptorassociated death domain protein) and downstream JNK (c-Jun N-terminal kinase), NF-kappaB (Nuclear factor kappa B) and WWOX/WOX1 (WW domain-containing oxidoreductase)
2114880414), including 58 dementia family caregivers and 74 non-caregivers, blood samples were analyzed for interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, and telomere length, a measure of cell aging
21148804Abuse was associated with heightened IL-6 and TNF-alpha levels; for TNF-alpha, this relationship was magnified in caregivers compared with controls
24281089Proinflammatory cytokines, such as tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma, as well as chemokines and prostaglandins, are synthesized by resident brain cells and lymphocytes invading the affected brain tissue
20016203The basal and stimulated (by TNF-alpha) levels of NFkappaB were augmented in senescent cells in electrophoretic mobility shift assays in association with increased oxidative stress, increased p53 protein stability, and activated apoptotic pathways
20016134RESULTS: Senescent A549 cells and HDMECs, whether stimulated with lipopolysaccharide or not, produced greater amounts of IL-6, IL-8 and TNF-alpha, which paralleled NF-kappaB activation, than did presenescent cells
20006787Chronic inflammation, characterized by increased serum levels of tumor necrosis factor-alpha, interleukin-6, C-reactive protein, and plasminogen activator inhibitor-1, and the presence of inflammatory-related diseases, are seen commonly in aging
19584087We have identified a significantly altered cellular phenotype in response to chronic hypoxia as characterized by increased receptor-mediated apoptotic resistance, the induction of cellular senescence, increased invasion and the increased secretion of IL-1 beta, IL6, IL8 and TNFalpha cytokines
19124561We therefore studied the senescence of proliferative human EPCs and investigated the effects of the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) on their senescence
19124561However, EPCs up-regulated the expression of the senescence-associated cell cycle arrest protein p16(INK4a) and markedly increased measured senescence levels when exposed to chronic TNF-alpha treatment
18180277OBJECTIVES: To study the clinical outcome, treatment response, T-cell subsets and functional consequences of a novel tumour necrosis factor (TNF) receptor type 1 (TNFRSF1A) mutation affecting the receptor cleavage site
18180277Apoptosis of PBMCs was studied by stimulation with TNFalpha in the presence of cycloheximide and annexin V staining
18178582Pathway analysis of the differently regulated proteins suggests an increase in p53 activity in the p53(K317R) thymocytes as well as a decrease in tumor necrosis factor alpha signaling
17785865Correspondingly, caregivers had significantly lower T cell proliferation but higher production of immune-regulatory cytokines (TNF-alpha and IL-10) than controls in response to stimulation in vitro
17202338To support this hypothesis, we show here that the reduction of Klotho expression and activity in both elderly and patients' lymphocytes occurs in concert with the down-regulation of T cell costimulatory molecule CD28, the latter known to be dependent on increased levels of TNF-alpha
17199788Serum oxidized low-density lipoprotein (ox-LDL), tumour necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) were also measured in both groups by ELISA
17199788TNF was also inversely associated with percentage telomerase activity in the whole group studied (r = -0
17199788In stepwise multiple linear regression, taking into consideration the most important characteristics of the HD patients and control group, the only significant predictors for percentage telomerase activity in PBMC were ox-LDL and TNF (beta = -0
17142862The upregulation of the transcription factor nuclear factor kappaB (NF-kappaB) in transformed hepatocytes, through the paracrine action of tumor necrosis factor-alpha from neighboring endothelia and inflammatory cells, may be critical for tumor progression given the mitogenic and anti-apoptotic properties of proteins encoded by many of NF-kappaB's target genes
16930678In this report, ICAM-1 accumulates in late passage endothelial cells when compared to early passage endothelial cells, yet ICAM-1 protein expression is attenuated when senescent cells are challenged by TNF-alpha (10ng/ml)
16300653Up-regulation of the transcription factor NF-kappaB in transformed hepatocytes, through the paracrine action of TNF-alpha from neighbouring endothelia and inflammatory cells, may be critical for tumour progression given the mitogenic and antiapoptotic properties of proteins encoded by many of NF-kappaB's target genes
15130673Cell death following stimulations: (i) corresponded to apoptosis, associated with necrosis at the end of the culture; (ii) was not, for its main part, mediated through CD95/CD178 or TNFRII/TNF alpha interactions; and (iii) occurred in spite of bcl-2 increased expression
13679081Matrix metalloproteinase-9 (MMP-9) expression was also increased in response to tumor necrosis factor-alpha (TNF-alpha) in aged MASMC, as evidenced by zymography and immunoblot analysis
13679081Transient transfection assays showed an age-dependent increase in transcription from MMP-9 promoter activity in response to TNF-alpha
12569699The hTERT positive fibroblasts could form bone nodules when they were cultured in vitro induced by bone morphogentic protein 2 and tumor necrosis factor-alpha
11855860We have found that human senescent fibroblasts can be induced to undergo programmed cell death (apoptosis) by ceramide, TNF-alpha, or okadaic acid
11855860The most profound effects were induced by TNF-alpha and okadaic acid treatment
11855860TNF-alpha was the only agent that induced lysosomal activity in senescent fibroblasts, of which only alpha-galactosidase A activity was induced
11828880Energetic stress in combination with tumor necrosis factor-alpha (TNF-alpha) induces apoptosis of human fibroblasts (WI-38) in vitro: reduced responsiveness of senescent cells
118288804%) under treatment with either a high-NaCl medium or TNF-alpha (10 nM) alone, combined treatment resulted in a strong increase in Phase II cells and a significantly lesser rise in the case of "senescent" Phase III cells
11828880We conclude, therefore, that energetic stress stimulates sensitivity to apoptosis by (in the presence of) TNF-alpha, especially pronounced in potentially replicating "young" as compared with irreversible postmitotic ("senescent") fibroblasts
11679409To investigate a specific function modulated by endothelial NO, adhesion of monocytes under basal conditions as well as after exposure to TNF-alpha was assessed
11679409Exposure of TNF-alpha resulted in a 2-fold increase in monocyte adhesion in senescent cells, whereas this effect was reduced in cells transfected with hTERT
11480555Ceramide levels are elevated in response to diverse stress challenges including chemotherapeutic drug treatment, irradiation, or treatment with pro-death ligands such as tumor necrosis factor alpha, TNF alpha
10094826Transient transfection assays with TK5-CAT and TK10-CAT plasmids carrying NF-kappaB-responsive sites of the TNFalpha promoter were used to analyze the functional activity of the NF-kappaB complexes
8688670CD95 (APO-1) is a member of the TNF/nerve growth factor receptor superfamily, which is expressed on the surface of different types of cells
7561522In addition, lipopolysaccharide (LPS) was synergistic with IL-1 beta or tumor necrosis factor-alpha (TNF-alpha) in induction of nitric oxide synthesis
7561522Rat and mouse fibroblasts were also found to produce nitric oxide when primed with IFN-gamma and simultaneously treated with IL-1, TNF-alpha, or LPS
7561522Furthermore, effective triggering doses of LPS, TNF-alpha, and IL-1 were 10 ng/ml, 100 U/ml, and 0
7561522At the stage of growth crisis, a dramatic increase in nitric oxide production was observed in rat fibroblasts in response to IFN-gamma or TNF-alpha that may be directly correlated with cellular senescence
7737374The short-term growth of these cells in culture is regulated by a number of different cytokines, including tumor necrosis factor (TNF), interleukin-1 (IL-1), and fibroblast growth factor (FGF)
7737374In the present report, we examined the effects of TNF on foreskin-derived HDF at different passage levels
7737374Young cells proliferated in response to TNF in a dose-dependent manner
7737374Under these conditions TNF had no effect on senescent HDF
7737374The decrease in TNF responsiveness was found to be dependent on PD
7737374The lack of response of senescent HDF was not unique to TNF, since FGF and IL-1 were also ineffective
7737374On exposure to TNF, senescent HDF produced IL-6 and IL-8, but to a much lower degree than that produced by young HDF
7737374The diminished responsiveness of senescent HDF to TNF does not appear to be due to the difference in either receptor number or affinity, since senescent cells had two- to threefold higher number of TNF receptors than young HDF but the same affinity
7737374TNF induced the activation of a nuclear transcriptional factor, NF-kappa B, equally in both young and senescent cells, which indicates the lack of a defect in the early events of TNF signal transduction in senescent fibroblasts
7737374Overall, our results indicate that there is an age-dependent decline in TNF-induced proliferation and in the production of interleukins by fibroblasts; this unresponsiveness appears not to be due to TNF receptors or NF-kappa B activation
7862174Arguments will then be developed in favor of the implication of the ROS in the cellular effects of PMA, TNF-alpha and other cytokines on the modulation of the genetic expression
8262134We have studied changes in gene expression induced in these cells following exposure to the cytokine, tumor necrosis factor-alpha (TNF)
8359220Here we show that (i) senescence enhances monoblastoid U937 cell adhesion to the endothelial monolayer; (ii) the enhanced interaction between senescent endothelial cells and U937 cells is mediated, at least in part, by the overexpression of ICAM-1; and (iii) LPS and interleukin 1 alpha, but not tumor necrosis factor alpha, are unable to stimulate the adhesion of U937 to senescent endothelial cells
8376318Tumor necrosis factor-alpha (TNF) and various interferons (IFN) have potent cytostatic or cytotoxic effects on a variety of human tumor-derived cell lines
8376318We have examined the effects of TNF and IFN-beta on the proliferation of WI-38 cells in a serum-free, growth factor-supplemented medium and in serum-containing medium
8376318TNF has no effect on this growth factor-stimulated proliferation
8376318TNF and IFN-beta together have a synergistic effect and completely inhibit growth factor-stimulated DNA synthesis in young cells
8376318TNF stimulated an increase in the number of EGF specific binding sites two- to threefold in 24 h in both young and senescent cells
8376318IFN-beta has little or no effect on EGF binding either alone or in combination with TNF
Entries Per Page
Displaying Page of